3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
blinatumomab
10
Cyclophosphamide
6
fludarabine
4
Vincristine
4
Methotrexate
4
Dexamethasone
4
Cytarabine
4
venetoclax
3
Whole-Body Irradiation
2
Thiotepa
2
Therapeutics
2
Mercaptopurine
2
Exercise
2
Busulfan
2
ruxolitinib
1
revumenib
1
ponatinib
1
pegaspargase
1
olverembatinib
1
navitoclax
1
fludarabine phosphate
1
etoposide phosphate
1
capivasertib
1
asciminib
1
Ultrasonography
1
Transplantation
1
Prednisolone
1
Melphalan
1
Levofloxacin
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
CVAD protocol
×
Clear all
NCT07223190
2026-03-04
AUDAX
Amgen
Phase 3
Not yet recruiting
560 enrolled